UCB Ventures

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Switch Therapeutics is a biotech company that develops RNAi therapies.

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.

soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.

StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.